Showing results (1991-2000 of 19,554) with videos related to
Sort By:
Pageof 1,956
BMC Cancer|December 2, 2008
Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptorJennifer P Montgomery, Paul H PattersonBMC Cancer|December 3, 2008
Association of the germline TP53 R337H mutation with breast cancer in southern BrazilJuliana G Assumpção, Ana Luíza Seidinger, Maria José Mastellaro, et al.BMC Cancer|November 4, 2008
Voluntary exercise inhibits intestinal tumorigenesis in Apc(Min/+) mice and azoxymethane/dextran sulfate sodium-treated miceJihyeung Ju, Bonnie Nolan, Michelle Cheh, et al.BMC Cancer|November 5, 2008
Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian populationKrisztián Bácsi, Erika Hitre, János P Kósa, et al.BMC Cancer|June 30, 2009
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenibMarius Horger, Ulrich M Lauer, Christina Schraml, et al.BMC Cancer|July 1, 2009
A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancerRobert U Newton, Dennis R Taaffe, Nigel Spry, et al.BMC Cancer|July 2, 2009
The prosurvival role of autophagy in Resveratrol-induced cytotoxicity in human U251 glioma cellsJun Li, Zhenghong Qin, Zhongqin LiangBMC Cancer|April 16, 2009
Cetuximab in combination with irinotecan/5-fluorouracil/folinic acid (FOLFIRI) in the initial treatment of metastatic colorectal cancer: a multicentre two-part phase I/II studyJean-Luc Raoul, Jean-Luc Van Laethem, Marc Peeters, et al.BMC Cancer|June 25, 2009
P-gp activity is a critical resistance factor against AVE9633 and DM4 cytotoxicity in leukaemia cell lines, but not a major mechanism of chemoresistance in cells from acute myeloid leukaemia patientsRuoping Tang, Simy Cohen, Jean-Yves Perrot, et al.BMC Cancer|July 3, 2009
Response of the primary tumor in symptomatic and asymptomatic stage IV colorectal cancer to combined interventional endoscopy and palliative chemotherapySilke Cameron, Diana Hünerbein, Tümen Mansuroglu, et al.Pageof 1,956